Arcadia Biosciences
RKDA
Operating Margin for Arcadia Biosciences (RKDA)
Operating Margin as of April 2024 (TTM): -191.15%
According to Arcadia Biosciences's latest financial reports and stock price the company's current Operating Margin is -191.15%. At the end of 2021 the company had an Operating Margin of -237.94%.
Operating Margin history for Arcadia Biosciences from 2014 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -237.94% | 210.82% |
| 2020 | -76.55% | -96.9% |
| 2019 | -2,469.72% | 168.42% |
| 2018 | -920.08% | 136.23% |
| 2017 | -389.49% | -36.64% |
| 2016 | -614.77% | 85.63% |
| 2015 | -331.18% | 34.87% |
| 2014 | -245.55% | 42.19% |
| 2013 | -172.69% | 17.44% |
| 2012 | -147.05% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Marrone Bio Innovations
MBII | 0.00% | N/A | 🇺🇸 USA |
 Codexis
CDXS | -40.92% | -78.59% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | -4.47% | -97.66% | 🇺🇸 USA |
 American Vanguard AVD | 5.89% | -103.08% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.